Functional roles of sphingolipids in immunity and their implication in disease

참고문헌 (225)

1. Marshall, J. S., "An introduction to immunology and immunopathology", Allergy Asthma Clin. Immunol, 14, pp.49~ (2018)
2. Ochando, J., "Trained immunity—basic concepts and contributions to immunopathology", Nat. Rev. Nephrol, 19, pp.23~37 (2023)
3. Pramod Darvin, "Immune checkpoint inhibitors: recent progress and potential biomarkers", Experimental and Molecular Medicine, 50, pp.1~11 (2018), 생화학분자생물학회
4. Hannun, Y. A., "Sphingolipids and their metabolism in physiology and disease", Nat. Rev. Mol. Cell Biol, 19, pp.175~191 (2018)
5. Merrill, A. H. Jr, "Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics", Chem. Rev, 111, pp.6387~6422 (2011)
6. Luo, J., "Mechanisms and regulation of cholesterol homeostasis", Nat. Rev. Mol. Cell Biol, 21, pp.225~245 (2020)
7. Maceyka, M., "Sphingolipid metabolites in inflammatory disease", Nature, 510, pp.58~67 (2014)
8. Milhas, D, "Sphingomyelin metabolism at the plasma membrane: implications for bioactive sphingolipids", FEBS Lett, 584, pp.1887~1894 (2010)
9. Bornancin, F., "Ceramide kinase : the first decade", Cell. Signal, 23, pp.999~1008 (2011)
10. Diaz Escarcega, R., "The functional role of sphingosine kinase 2", Front. Mol. Biosci, 8, pp.683767~ (2021)
11. Hait, N. C., "The role of sphingosine-1-phosphate and ceramide-1-phosphate in inflammation and cancer", Mediators Inflamm, 2017, pp.4806541~ (2017)
12. Gómez-Muñoz, A., "Ceramide-1-phosphate blocks apoptosis through inhibition of acid sphingomyelinase in macrophages", J. Lipid Res, 45, pp.99~105 (2004)
13. Granado, M. H., "Ceramide 1-phosphate inhibits serine palmitoyltransferase and blocks apoptosis in alveolar macrophages", Biochim. Biophys. Acta, 1791, pp.263~272 (2009)
14. Clair, T., "Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate", Cancer Res, 63, pp.5446~5453 (2003)
15. van Meeteren, L. A., "Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate", J. Biol. Chem, 280, pp.21155~21161 (2005)
16. Wang, J., "Functions of sphingolipids in pathogenesis during host–pathogen interactions", Front. Microbiol, 12, pp.701041~ (2021)
17. Brown, E. M., "Bacteroides-derived sphingolipids are critical for maintaining intestinal homeostasis and symbiosis", Cell Host Microbe, 25, pp.668~680 (2019)
18. Johnson, E. L., "Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels", Nat. Commun, 11, pp.2471~ (2020)
19. Mingyu Lee, "Emerging roles of neutrophils in immune homeostasis", BMB Reports, 55(10), pp.473~480 (2022), 생화학분자생물학회
20. ElTanbouly, M. A, "Rethinking peripheral T cell tolerance: checkpoints across a T cell’s journey", Nat. Rev. Immunol, 21, pp.257~267 (2021)
21. Brown, G. R., "Gene : a gene-centered information resource at NCBI", Nucleic Acids Res, 43, pp.D36~D42 (2015)
22. Apostolidis, S. A., "Phosphatase PP2A is requisite for the function of regulatory T cells", Nat. Immunol, 17, pp.556~564 (2016)
23. MacKichan, M. L., "Role of ceramide in lipopolysaccharide (LPS)-induced signaling. LPS increases ceramide rather than acting as a structural homolog", J. Biol. Chem, 274, pp.1767~1775 (1999)
24. Chen, C. L., "Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway", Blood, 111, pp.4365~4374 (2008)
25. Trayssac, M., "Role of sphingolipids in senescence : implication in aging and age-related diseases", J. Clin. Invest, 128, pp.2702~2712 (2018)
26. Sallusto, F., "Ceramide inhibits antigen uptake and presentation by dendritic cells", J. Exp. Med, 184, pp.2411~2416 (1996)
27. Hoeferlin, L. A., "The role of ceramide-1-phosphate in biological functions", Handb. Exp. Pharmacol, 215, pp.153~166 (2013)
28. Ueda, N., "Ceramide-induced apoptosis in renal tubular cells : a role of mitochondria and sphingosine-1-phoshate", Int. J. Mol. Sci, 16, pp.5076~5124 (2015)
29. Matas-Rico, E., "Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8(+)T cells", Cell Rep, 37, pp.110013~ (2021)
30. Ogretmen, B., "Sphingolipid metabolism in cancer signalling and therapy", Nat. Rev. Cancer, 18, pp.33~50 (2018)
31. Barry, B., "Fingolimod rebound : a review of the clinical experience and management considerations", Neurol. Ther, 8, pp.241~250 (2019)
32. Shaw, J., "Novel sphingolipid-based cancer therapeutics in the personalized medicine era", Adv. Cancer Res, 140, pp.327~366 (2018)
33. Canals, D., "Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases", Br. J. Pharm, 163, pp.694~712 (2011)
34. Wigger, L., "Plasma dihydroceramides are diabetes susceptibility biomarker candidates in mice and humans", Cell Rep, 18, pp.2269~2279 (2017)
35. Do, J., "Glucocerebrosidase and its relevance to Parkinson disease", Mol. Neurodegener, 14, pp.36~ (2019)
36. Gril, B., "Reactive astrocytic S1P3 signaling modulates the blood-tumor barrier in brain metastases", Nat. Commun, 9, pp.2705~ (2018)
37. Song, S., "S1PR1 predicts patient survival and promotes chemotherapy drug resistance in gastric cancer cells through STAT3 constitutive activation", EBio-Medicine, 37, pp.168~176 (2018)
38. Matula, K., "Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer", BMC Cancer, 15, pp.762~ (2015)
39. Wang, S., "Triple negative breast cancer depends on sphingosine kinase 1(SphK1)", sphingosine-1-phosphate(S1P), notch signaling for metastasis, pp.Med. Sci. Moni. Basic Res, 2018[DOI]
40. Sun, Y., "Multi-Omics prognostic signatures based on lipid metabolism for colorectal cancer", Front. Cell Dev. Biol, 9, pp.811957~ (2022)
41. Baloni, P., "Multi-Omic analyses characterize the ceramide", sphingomyelin pathway as a therapeutic target in Alzheimer’s disease, 2022, pp.5, 1074~
42. Huang, X., "Multi-platform omics analysis reveals molecular signatures for pathogenesis and activity of systemic lupus erythematosus", Front. Immunol, 13, pp.833699~ (2022)
43. Hu, C., "Multi-omics profiling : the way toward precision medicine in metabolic diseases", J. Mol. Cell Biol, 13, pp.576~593 (2021)
44. Johnson, C. H., "Metabolomics : beyond biomarkers and towards mechanisms", Nat. Rev. Mol. Cell Biol, 17, pp.451~459 (2016)
45. Aderemi, A. V., "Metabolomics : a scoping review of its role as a tool for disease biomarker discovery in selected non-communicable diseases", Metabolites, 11, pp.418~ (2021)
46. Wigger, D., "Monitoring the sphingolipid de novo synthesis by stable-isotope labeling and liquid chromatography-mass spectrometry", Front. Cell Dev. Biol, 7, pp.210~ (2019)
47. Scherer, M., "A rapid and quantitative LC-MS", MS method to profile sphingolipids, 2010, pp.51, 2001~2011
48. Garris, C. S., "Defective sphingosine 1-phosphate receptor 1(S1P1)phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation", Nat. Immunol, 14, pp.1166~1172 (2013)
49. Ghidoni, R., "Role of sphingolipids in the pathobiology of lung inflammation", Mediators Inflamm, 2015, pp.487508~ (2015)
50. Nagahashi, M., "High levels of sphingolipids in human breast cancer", J. Surg. Res, 204, pp.435~444 (2016)
51. Tsugawa, H., "Comprehensive identification of sphingolipid species by in silico retention time and tandem mass spectral library", J. Cheminformatics, 9, pp.19~ (2017)
52. Muralidharan, S., "A reference map of sphingolipids in murine tissues", Cell Rep, 35, pp.109250~ (2021)
53. Wang, J., "Functions of sphingolipids in pathogenesis during host-pathogen interactions", Front. Microbiol, 12, pp.701041~ (2021)
54. Huang, L., "Circulating saturated fatty acids and incident type 2 diabetes : a systematic review and meta-analysis", Nutrients, 11, pp.998~ (2019)
55. Zhu, S., "Ceramide kinase mediates intrinsic resistance and inferior response to chemotherapy in triple-negative breast cancer by upregulating Ras", ERK and PI3K, Cancer Cell Int, pp.2021, 21[DOI]
56. Bhadwal, P., "Clinical relevance of CERK and SPHK1 in breast cancer and their association with metastasis and drug resistance", Sci. Rep, 12, pp.18239~ (2022)
57. Jacobi, J., "Targeting acid sphingomyelinase with anti-angiogenic chemotherapy", Cell. Signal, 29, pp.52~61 (2017)
58. Garrido, M., "Azide-tagged sphingolipids : new tools for metabolic flux analysis", Chembiochem, 16, pp.641~650 (2015)
59. Fink, J., "Azidosphinganine enables metabolic labeling and detection of sphingolipid de novo synthesis", Org. Biomol. Chem, 19, pp.2203~2212 (2021)
60. Götz, R., "Nanoscale imaging of bacterial infections by sphingolipid expansion microscopy", Nat. Commun, 11, pp.6173~ (2020)
61. Wang Wei, "Nanoscale fluorescence imaging of biological ultrastructure via molecular anchoring and physical expansion", Nano Convergence, 9(30), pp.1~28 (2022), 나노기술연구협의회[DOI]
62. Rohrhofer, J., "The impact of dietary sphingolipids on intestinal microbiota and gastrointestinal immune homeostasis", Front. Immunol, 12, pp.635704~ (2021)
63. Verhaegh, R., "Sphingosine kills bacteria by binding to cardiolipin", J. Biol. Chem, 295, pp.7686~7696 (2020)
64. Wu, Y., "The anti-infectious role of sphingosine in microbial diseases", Cells, 10, pp.1105~ (2021)
65. Chiricozzi, E., "Sphingolipids role in the regulation of inflammatory response : from leukocyte biology to bacterial infection", J. Leukoc. Biol, 103, pp.445~456 (2018)
66. Chen, K., "Rethinking mucosal antibody responses : IgM, IgG and IgD join IgA", Nat. Rev. Immunol, 20, pp.427~441 (2020)
67. Xu, D., "Defensins : a double-edged sword in host immunity", Front. Immunol, 11, pp.764~ (2020)
68. Linden, S. K., "Mucins in the mucosal barrier to infection", Mucosal Immunol, 1, pp.183~197 (2008)
69. Baeyens, A. A. L., "Finding a way out : S1P signaling and immune cell migration", Annu. Rev. Immunol, 38, pp.759~784 (2020)
70. Bryan, A. M., "Sphingosine-1-phosphate receptors and innate immunity", Cell. Immunol, 20, pp.e12836~ (2018)
71. Orsini, M., "Sphingolipid-mediated inflammatory signaling leading to autophagy inhibition converts erythropoiesis to myelopoiesis in human hematopoietic stem", progenitor cells, 2019, pp.26, 1796~1812
72. Nakamura, T., "Ceramide regulates oxidant release in adherent human neutrophils", J. Biol. Chem, 269, pp.18384~18389 (1994)
73. Zhao, X., "Neutrophil recruitment mediated by sphingosine 1-phosphate(S1P)", S1P receptors during chronic liver injury, 2021, pp.359, 104243~
74. Karandashova, S., "Neutrophil elastase increases airway ceramide levels via upregulation of serine palmitoyltransferase", Am. J. Physiol. Lung Cell Mol. Physiol, 314, pp.L206~l214 (2018)
75. Izawa, K., "Disrupting ceramide-CD300f interaction prevents septic peritonitis by stimulating neutrophil recruitment", Sci. Rep, 7, pp.4298~ (2017)
76. Meher, A. K., "Novel role of IL(Interleukin)-1β in neutrophil extracellular trap formation and abdominal aortic aneurysms", Arterioscler. Thromb. Vasc. Biol, 38, pp.843~853 (2018)
77. Mansfield, P. J., "Regulation of polymorphonuclear leukocyte degranulation and oxidant production by ceramide through inhibition of phospholipase D", Blood, 99, pp.1434~1441 (2002)
78. Qureshi, A., "Role of sphingomyelin synthase in controlling the antimicrobial activity of neutrophils against Cryptococcus neoformans", PLoS ONE, 5, pp.e15587~ (2011)
79. Eberle, M., "Exacerbation of experimental autoimmune encephalomyelitis in ceramide synthase 6 knockout mice is associated with enhanced activation", migration of neutrophils, 2015, pp.93, 825~836
80. Barthelmes, J., "Lack of ceramide synthase 2 suppresses the development of experimental autoimmune encephalomyelitis by impairing the migratory capacity of neutrophils", Brain Behav. Immun, 46, pp.280~292 (2015)
81. Hinkovska-Galcheva, V. T., "The formation of ceramide-1-phosphate during neutrophil phagocytosis and its role in liposome fusion", J. Biol. Chem, 273, pp.33203~33209 (1998)
82. Hinkovska-Galcheva, V., "Ceramide 1-phosphate, a mediator of phagocytosis", J. Biol. Chem, 280, pp.26612~26621 (2005)
83. Seumois, G., "De novo C16-and C24-ceramide generation contributes to spontaneous neutrophil apoptosis", J. Leukoc. Biol, 81, pp.1477~1486 (2007)
84. Baeyens, A., "Monocyte-derived S1P in the lymph node regulates immune responses", Nature, 592, pp.290~295 (2021)
85. Al-Rashed, F., "Ceramide kinase regulates TNF-α-induced immune responses in human monocytic cells", Sci. Rep, 11, pp.8259~ (2021)
86. Syed, S. N., "Sphingosine kinases are involved in macrophage NLRP3 inflammasome transcriptional induction", Int. J. Mol. Sci, 21, pp.4733~ (2020)
87. Coillard, A., "In vivo differentiation of human monocytes", Front. Immunol, 10, pp.1907~ (2019)
88. Weichand, B., "Apoptotic cells enhance sphingosine-1-phosphate receptor 1dependent macrophage migration", Eur. J. Immunol, 43, pp.3306~3313 (2013)
89. Weigert, A., "Sphingosine-1-phosphate and macrophage biology-how the sphinx tames the big eater", Front. Immunol, 10, pp.1706~ (2019)
90. Yang, J., "Sphingosine 1-phosphate(S1P)", S1P receptor2, macrophage via G(α)i, pp.o, PI3K[DOI]
91. Hou, J., "Sphingosine 1-phosphate receptor 2 signaling suppresses macrophage phagocytosis and impairs host defense against sepsis", Anesthesiology, 123, pp.409~422 (2015)
92. Hou, L., "Macrophage sphingosine 1-phosphate receptor 2 blockade attenuates liver inflammation and fibrogenesis triggered by NLRP3 inflammasome", Front. Immunol, 11, pp.1149~ (2020)
93. Lamour, N. F., "Ceramide kinase regulates the production of tumor necrosis factor α(TNFα)via inhibition of TNFα-converting enzyme", J. Biol. Chem, 286, pp.42808~42817 (2011)
94. Uribe-Querol, E., "Phagocytosis : our current understanding of a universal biological process", Front. Immunol, 11, pp.1066~ (2020)
95. Niekamp, P., "Sphingomyelin biosynthesis is essential for phagocytic signaling during Mycobacterium tuberculosis host cell entry", mBio, 12, pp.e03141~ (2021)
96. Mehendale, N., "Mapping sphingolipid metabolism pathways during phagosomal maturation", ACS Chem. Biol, 16, pp.2757~2765 (2021)
97. Grassmé, H., "Acidic sphingomyelinase mediates entry of N. gonorrhoeae into nonphagocytic cells", Cell, 91, pp.605~615 (1997)
98. Yu, H., "Defective acid sphingomyelinase pathway with Pseudomonas aeruginosa infection in cystic fibrosis", Am. J. Respir. Cell Mol. Biol, 41, pp.367~375 (2009)
99. Krones, D., "Staphylococcus aureus α-toxin induces acid sphingomyelinase release from a human endothelial cell line", Front. Microbiol, 12, pp.694489~ (2021)
100. Zhang, Y., "Acid sphingomyelinase amplifies redox signaling in Pseudomonas aeruginosa-induced macrophage apoptosis", J. Immunol, 181, pp.4247~4254 (2008)
101. Managò, A., "Pseudomonas aeruginosa pyocyanin induces neutrophil death via mitochondrial reactive oxygen species and mitochondrial acid sphingomyelinase", Antioxid. Redox Signal, 22, pp.1097~1110 (2015)
102. Tafesse, F. G., "Disruption of sphingolipid biosynthesis blocks phagocytosis of Candida albicans", PLoS Pathog, 11, pp.e1005188~ (2015)
103. Lang, J., "Acid ceramidase of macrophages traps herpes simplex virus in multivesicular bodies and protects from severe disease", Nat. Commun, 11, pp.1338~ (2020)
104. Doran, A. C., "Efferocytosis in health and disease", Nat. Rev. Immunol, 20, pp.254~267 (2020)
105. Feng, J., "Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma", J. Lipid Res, 41, pp.688~696 (2000)
106. Hundal, R. S., "Oxidized low density lipoprotein inhibits macrophage apoptosis through activation of the PI 3-kinase", PKB pathway, 2001, pp.42, 1483~1491
107. i increases in renal mesangial cells, "Biochim Biophys. Acta", 2013, 1634~1643 (1831)
108. Coazzoli, M., "Acid sphingomyelinase downregulation enhances mitochondrial fusion and promotes oxidative metabolism in a mouse model of melanoma", Cells, 9, pp.848~ (2020)
109. McCarthy, C., "Macrophage PPAR gamma Co-activator-1 alpha participates in repressing foam cell formation and atherosclerosis in response to conjugated linoleic acid", EMBO Mol. Med, 5, pp.1443~1457 (2013)
110. Luan, Y., "Ceramides reduce CD36 cell surface expression and oxidised LDL uptake by monocytes and macrophages", Arch. Biochem. Biophys, 450, pp.89~99 (2006)
111. Marathe, S., "Sphingomyelinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix", Arterioscler. Thromb. Vasc. Biol, 19, pp.2648~2658 (1999)
112. Petrusca, D. N., "Sphingolipid-mediated inhibition of apoptotic cell clearance by alveolar macrophages", J. Biol. Chem, 285, pp.40322~40332 (2010)
113. Camell, C. D., "Macrophage-specific de novo synthesis of ceramide is dispensable for inflammasome-driven inflammation and insulin resistance in obesity", J. Biol. Chem, 290, pp.29402~29413 (2015)
114. Liu, J., "Dendritic cell migration in inflammation and immunity", Cell. Mol. Immunol, 18, pp.2461~2471 (2021)
115. Idzko, M., "Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in mature human dendritic cells for emergence of Th2 immune responses", FASEB J, 16, pp.625~627 (2002)
116. Avota, E., "DC-SIGN mediated sphingomyelinase-activation and ceramide generation is essential for enhancement of viral uptake in dendritic cells", PLoS Pathog, 7, pp.e1001290~ (2011)
117. Zhao, D., "Inhibition of acid ceramidase regulates MHC class II antigen presentation and suppression of autoimmune arthritis", Cytokine, 135, pp.155219~ (2020)
118. Hartel, J. C., "How sphingolipids affect T cells in the resolution of inflammation", Front. Pharmacol, 13, pp.1002915~ (2022)
119. Franchi, L., "Ceramide catabolism critically controls survival of human dendritic cells", J. Leukoc. Biol, 79, pp.166~172 (2006)
120. Eigenbrod, S., "Sphingosine kinase and sphingosine-1-phosphate regulate migration, endocytosis and apoptosis of dendritic cells", Immunol. Invest, 35, pp.149~165 (2006)
121. Schwiebs, A., "Activation-induced cell death of dendritic cells is dependent on sphingosine kinase 1", Front. Pharmacol, 7, pp.94~ (2016)
122. Kanto, T., "Ceramide mediates tumor-induced dendritic cell apoptosis", J. Immunol, 167, pp.3773~3784 (2001)
123. Koeken, V. A. C. M., "Plasma metabolome predicts trained immunity responses after antituberculosis BCG vaccination", PLoS Biol, 20, pp.e3001765~ (2022)
124. Mendoza, A., "Lymphatic endothelial S1P promotes mitochondrial function and survival in naive T cells", Nature, 546, pp.158~161 (2017)
125. Xiong, Y., "CD4 T cell sphingosine 1-phosphate receptor (S1PR)1 and S1PR4and endothelial S1PR2 regulate afferent lymphatic migration", Sci. Immunol, 4, pp.eaav1263~ (2019)
126. Liu, G., "The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR", Nat. Immunol, 10, pp.769~777 (2009)
127. Liu, G., "The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg)cells", Nat. Immunol, 11, pp.1047~1056 (2010)
128. Brana, C., "Immunohistochemical detection of sphingosine-1-phosphate receptor 1 and 5 in human multiple sclerosis lesions", Neuropathol. Appl. Neurobiol, 40, pp.564~578 (2014)
129. Xiao, L., "SPHK1-S1PR1-RANKL axis regulates the interactions between macrophages and BMSCs in inflammatory bone loss", J. Bone Miner. Res, 33, pp.1090~1104 (2018)
130. Ryu, J., "Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling", EMBO J, 25, pp.5840~5851 (2006)
131. Contos, J. J., "Lysophosphatidic acid receptors", Mol. Pharmacol, 58, pp.1188~1196 (2000)
132. Brinkmann, V., "Fingolimod(FTY720) : discovery and development of an oral drug to treat multiple sclerosis", Nat. Rev. Drug Discov, 9, pp.883~897 (2010)
133. Sun, Y., "Ozanimod for treatment of relapsing-remitting multiple sclerosis in adults : a systematic review and meta-analysis of randomized controlled trials", Front. Pharmacol, 11, pp.589146~ (2020)
134. Companioni, O., "Targeting sphingolipids for cancer therapy", Front. Oncol, 11, pp.745092~ (2021)
135. Martín-Leal, A., "CCR5 deficiency impairs CD4(+)T-cell memory responses and antigenic sensitivity through increased ceramide synthesis", EMBO J, 39, pp.e104749~ (2020)
136. Tonnetti, L., "A role for neutral sphingomyelinase-mediated ceramide production in T cell receptor-induced apoptosis and mitogen-activated protein kinase-mediated signal transduction", J. Exp. Med, 189, pp.1581~1589 (1999)
137. Bai, A., "Role of acid sphingomyelinase bioactivity in human CD4+ T-cell activation and immune responses", Cell Death Dis, 6, pp.e1828~e1828 (2015)
138. Chan, G., "Sphingomyelin-ceramide turnover in CD28 costimulatory signaling", Eur. J. Immunol, 25, pp.1999~2004 (1995)
139. Stoffel, B., "Ceramide-independent CD28and TCR signaling but reduced IL-2 secretion in T cells of acid sphingomyelinase-deficient mice", Eur. J. Immunol, 28, pp.874~880 (1998)
140. Bai, A., "CD39 and CD161 modulate Th17 responses in Crohn’s disease", J. Immunol, 193, pp.3366~3377 (2014)
141. Hose, M., "T cell-specific overexpression of acid sphingomyelinase results in elevated T cell activation and reduced parasitemia during Plasmodium yoelii infection", Front. Immunol, 10, pp.1225~ (2019)
142. Hollmann, C., "Inhibition of acid sphingomyelinase allows for selective targeting of CD4+ conventional versus Foxp3+ regulatory T cells", J. Immunol, 197, pp.3130~3141 (2016)
143. Sharabi, A., "PP2A enables IL-2 signaling by preserving IL-2Rβ chain expression during Treg development", JCI Insight, 5, pp.e126294~ (2019)
144. Tang, Q., "Therapeutic window of interleukin-2 for autoimmune diseases", Diabetes, 64, pp.1912~1913 (2015)
145. Studstill, C. J., "Sphingosine kinase 2 restricts T cell immunopathology but permits viral persistence", J. Clin. Investig, 130, pp.6523~6538 (2020)
146. Lau, P., "Sphingosine kinase 1 promotes tumor immune evasion by regulating the MTA3-PD-L1 axis", Cell. Mol. Immunol, 19, pp.1153~1167 (2022)
147. Peyruchaud, O., "Autotaxin implication in cancer metastasis and autoimunne disorders : functional implication of binding autotaxin to the cell surface", Cancers, 12, pp.105~ (2019)
148. Kester, M., "Preclinical development of a C6-ceramide NanoLiposome, a novel sphingolipid therapeutic", Biol. Chem, 396, pp.737~747 (2015)
149. Sic, H., "Sphingosine-1-phosphate receptors control B-cell migration through signaling components associated with primary immunodeficiencies, chronic lymphocytic leukemia, and multiple sclerosis", J. Allergy Clin. Immunol, 134, pp.420~428 (2014)
150. Blaho, V. A., "An update on the biology of sphingosine 1-phosphate receptors", J. Lipid Res, 55, pp.1596~1608 (2014)
151. Green, J. A., "S1PR2 links germinal center confinement and growth regulation", Immunol. Rev, 247, pp.36~51 (2012)
152. Colié, S., "Disruption of sphingosine 1-phosphate lyase confers resistance to chemotherapy and promotes oncogenesis through Bcl-2", Bcl-xL upregulation, 2009, pp.69, 9346~9353
153. Furuya, H., "Sphingosine kinase 1 expression enhances colon tumor growth", J. Transl. Med, 15, pp.120~ (2017)
154. Oskouian, B., "Sphingosine-1-phosphate lyase potentiates apoptosis via p53-and p38-dependent pathways and is down-regulated in colon cancer", Proc. Natl Acad. Sci. USA, 103, pp.17384~17389 (2006)
155. Magkrioti, C., "The autotaxin-lysophosphatidic acid axis promotes lung carcinogenesis", Cancer Res, 78, pp.3634~3644 (2018)
156. Benesch, M. G., "Tumor-induced inflammation in mammary adipose tissue stimulates a vicious cycle of autotaxin expression and breast cancer progression", FASEB J, 29, pp.3990~4000 (2015)
157. Chen, W., "Downregulation of ceramide synthase 1 promotes oral cancer through endoplasmic reticulum stress", Int. J. Oral. Sci, 13, pp.10~ (2021)
158. El-Hindi, K., "T-cell-specific CerS4 depletion prolonged inflammation and enhanced tumor burden in the AOM", DSS-induced CAC model, 2022, pp.23, 1866~
159. Kachler, K., "Enhanced acid sphingomyelinase activity drives immune evasion and tumor growth in non-small cell lung carcinoma", Cancer Res, 77, pp.5963~5976 (2017)
160. Kato, Y., "Acidic extracellular pH increases calcium influx-triggered phospholipase D activity along with acidic sphingomyelinase activation to induce matrix metalloproteinase-9 expression in mouse metastatic melanoma", FEBS J, 274, pp.3171~3183 (2007)
161. Montfort, A., "Neutral sphingomyelinase 2 heightens anti-melanoma immune responses and anti-PD-1 therapy efficacy", Cancer Immunol. Res, 9, pp.568~582 (2021)
162. Akeus, P., "Regulatory T cells reduce endothelial neutral sphingomyelinase 2to prevent T-cell migration into tumors", Eur. J. Immunol, 51, pp.2317~2329 (2021)
163. Chakraborty, P., "Pro-survival lipid sphingosine-1-phosphate metabolically programs T cells to limit anti-tumor activity", Cell Rep, 28, pp.1879~1893 (2019)
164. Józefowski, S., "Ceramide and ceramide 1-phosphate are negative regulators of TNF-α production induced by lipopolysaccharide", J. Immunol, 185, pp.6960~6973 (2010)
165. Ali, M., "LPS-mediated septic shock is augmented in ceramide synthase 2 null mice due to elevated activity of TNFα-converting enzyme", FEBS Lett, 589, pp.2213~2217 (2015)
166. Tanaka, A., "Effects of ceramide kinase knockout on lipopolysaccharidetreated sepsis-model mice : changes in serum cytokine", chemokine levels and increased lethality, 2022, pp.150, 1~8
167. Espaillat, M. P., "Loss of acid ceramidase in myeloid cells suppresses intestinal neutrophil recruitment", FASEB J, 32, pp.2339~2353 (2018)
168. Graf, C., "Neutropenia with impaired immune response to Streptococcus pneumoniae in ceramide kinase-deficient mice", J. Immunol, 180, pp.3457~3466 (2008)
169. Claus, R. A., "Role of increased sphingomyelinase activity in apoptosis and organ failure of patients with severe sepsis", FASEB J, 19, pp.1719~1721 (2005)
170. Heinrich, M., "Cathepsin D links TNF-induced acid sphingomyelinase to Bidmediated caspase-9 and-3 activation", Cell Death Differ, 11, pp.550~563 (2004)
171. Utermöhlen, O., "Severe impairment in early host defense against Listeria monocytogenes in mice deficient in acid sphingomyelinase", J. Immunol, 170, pp.2621~2628 (2003)
172. Jin, J., "Acid sphingomyelinase plays a key role in palmitic acid-amplified inflammatory signaling triggered by lipopolysaccharide at low concentrations in macrophages", Am. J. Physiol. Endocrinol. Metab, 305, pp.E853~E867 (2013)
173. Ugwu, F. N., "Preclinical evidence of sphingosine kinase 1 inhibition in alleviation of intestinal epithelial injury in polymicrobial sepsis", Inflamm. Res, 68, pp.723~726 (2019)
174. Allende, M. L., "Sphingosine-1-phosphate lyase deficiency produces a proinflammatory response while impairing neutrophil trafficking", J. Biol. Chem, 286, pp.7348~7358 (2011)
175. Helke, K., "Ceramide synthase 6 deficiency enhances inflammation in the DSS model of colitis", Sci. Rep, 8, pp.1627~ (2018)
176. Suzuki, S., "Knockout of ceramide kinase aggravates pathological and lethal responses in mice with experimental colitis", Biol. Pharm. Bull, 41, pp.797~805 (2018)
177. Zhang, P., "Deficiency of alkaline SMase enhances dextran sulfate sodiuminduced colitis in mice with upregulation of autotaxin", J. Lipid Res, 59, pp.1841~1850 (2018)
178. Dong, Y. L., "Autotaxin-lysophosphatidic acid axis blockade improves inflammation by regulating Th17 cell differentiation in DSS-induced chronic colitis mice", Inflammation, 42, pp.1530~1541 (2019)
179. Lin, S., "Autotaxin determines colitis severity in mice and is secreted by B cells in the colon", FASEB J, 33, pp.3623~3635 (2019)
180. Tanaka, A., "Ceramide kinase knockout ameliorates multiple sclerosis-like behaviors and demyelination in cuprizone-treated mice", Life Sci, 296, pp.120446~ (2022)
181. Ninou, I., "Genetic deletion of autotaxin from CD11b+ cells decreases the severity of experimental autoimmune encephalomyelitis", PLoS ONE, 15, pp.e0226050~ (2020)
182. Becker, K. A., "Blockade of experimental multiple sclerosis by inhibition of the acid sphingomyelinase", ceramide system, 2017, pp.25, 88~97
183. Wang, C., "Sphingomyelin synthase 1 enhances BCR signaling to promote lupus-like autoimmune response", EBioMedicine, 45, pp.578~587 (2019)
184. Liu, F., "TLR-induced SMPD3 defects enhance inflammatory response of B cell and macrophage in the pathogenesis of SLE", Scand. J. Immunol, 86, pp.377~388 (2017)
185. Beckmann, N., "Regulation of arthritis severity by the acid sphingomyelinase", Cell. Physiol. Biochem, 43, pp.1460~1471 (2017)
186. Nikitopoulou, I., "Autotaxin expression from synovial fibroblasts is essential for the pathogenesis of modeled arthritis", J. Exp. Med, 209, pp.925~933 (2012)
187. Sofi, M. H., "Ceramide synthesis regulates T cell activity and GVHD development", JCI Insight, 2, pp.e91701~ (2017)
188. Herz, J., "Acid sphingomyelinase is a key regulator of cytotoxic granule secretion by primary T lymphocytes", Nat. Immunol, 10, pp.761~768 (2009)
189. Glajch, K. E., "Wild-type GBA1 increases the α-synuclein tetramer-monomer ratio, reduces lipid-rich aggregates, and attenuates motor and cognitive deficits in mice", Proc. Natl Acad. Sci. USA, 118, pp.e2103425118~ (2021)
190. Li, H., "Mitochondrial dysfunction and mitophagy defect triggered by heterozygous GBA mutations", Autophagy, 15, pp.113~130 (2019)
191. Pandey, M. K., "Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease", Nature, 543, pp.108~112 (2017)
192. Pandey, M. K., "Immunological cell type characterization and Th1-Th17 cytokine production in a mouse model of Gaucher disease", Mol. Genet. Metab, 106, pp.310~322 (2012)
193. Sikora, J., "Acid ceramidase deficiency in mice results in a broad range of central nervous system abnormalities", Am. J. Pathol, 187, pp.864~883 (2017)
194. Lee, J. K., "Acid sphingomyelinase modulates the autophagic process by controlling lysosomal biogenesis in Alzheimer’s disease", J. Exp. Med, 211, pp.1551~1570 (2014)
195. Lee, J. Y., "Neuronal SphK1 acetylates COX2 and contributes to pathogenesis in a model of Alzheimer’s Disease", Nat. Commun, 9, pp.1479~ (2018)
196. Wang, P., "Aggravation of Alzheimer’s disease due to the COX-2-mediated reciprocal regulation of IL-1β and Aβ between glial and neuron cells", Aging Cell, 13, pp.605~615 (2014)
197. Alam, S., "Neurodegeneration caused by S1P-lyase deficiency involves calciumdependent tau pathology and abnormal histone acetylation", Cells, 9, pp.2189~ (2020)
198. Zhong, L., "Lipid transporter Spns2 promotes microglia pro-inflammatory activation in response to amyloid-beta peptide", Glia, 67, pp.498~511 (2019)
199. Lu, M. H., "Inhibition of sphingomyelin synthase 1 ameliorates alzheimer-like pathology in APP", PS1 transgenic mice through promoting lysosomal degradation of BACE1, 2019, pp.311, 67~79
200. Di Pardo, A., "Defective sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease", Sci. Rep, 7, pp.5280~ (2017)
201. Di Pardo, A., "Stimulation of sphingosine kinase 1(SPHK1)is beneficial in a Huntington’s disease pre-clinical model", Front. Mol. Neurosci, 12, pp.100~ (2019)
202. Worgall, T. S., "Impaired sphingolipid synthesis in the respiratory tract induces airway hyperreactivity", Sci. Transl. Med, 5, pp.186ra167~ (2013)
203. Oyeniran, C., "Aberrant ORM (yeast)-like protein isoform 3 (ORMDL3)expression dysregulates ceramide homeostasis in cells and ceramide exacerbates allergic asthma in mice", J. Allergy Clin. Immunol, 136, pp.1035~1046 (2015)
204. Li, J., "ORMDL3 functions as a negative regulator of antigen-mediated mast cell activation via an ATF6-UPR-autophagy-dependent pathway", Front. Immunol, 12, pp.604974~ (2021)
205. Bugajev, V., "Negative regulatory roles of ORMDL3 in the FcεRI-triggered expression of proinflammatory mediators and chemotactic response in murine mast cells", Cell. Mol. Life Sci, 73, pp.1265~1285 (2016)
206. Shin, S. H., "Ceramide synthase 2 null mice are protected from ovalbumininduced asthma with higher T cell receptor signal strength in CD4+ T cells", Int. J. Mol. Sci, 22, pp.2713~ (2021)
207. Ziobro, R., "Ceramide mediates lung fibrosis in cystic fibrosis", Biochem. Biophys. Res. Commun, 434, pp.705~709 (2013)
208. Dhami, R., "Acid sphingomyelinase deficiency attenuates bleomycin-induced lung inflammation and fibrosis in mice", Cell. Physiol. Biochem, 26, pp.749~760 (2010)
209. Becker, K. A., "Acid ceramidase rescues cystic fibrosis mice from pulmonary infections", Infect. Immun, 89, pp.e00677-20~ (2021)
210. Nordström, V., "Neuronal expression of glucosylceramide synthase in central nervous system regulates body weight and energy homeostasis", PLoS Biol, 11, pp.e1001506~ (2013)
211. Zhang, Q. J., "Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex", Diabetes, 61, pp.1848~1859 (2012)
212. Holland, W. L., "Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance", Cell Metab, 5, pp.167~179 (2007)
213. Song, Y., "Ablation of ORMDL3 impairs adipose tissue thermogenesis and insulin sensitivity by increasing ceramide generation", Mol. Metab, 56, pp.101423~ (2022)
214. Bandet, C. L., "Ceramide transporter CERT is involved in muscle insulin signaling defects under lipotoxic conditions", Diabetes, 67, pp.1258~1271 (2018)
215. Mitsutake, S., "Ceramide kinase deficiency improves diet-induced obesity and insulin resistance", FEBS Lett, 586, pp.1300~1305 (2012)
216. Barbarroja, N., "Increased dihydroceramide", ceramide ratio mediated by defective expression of degs1 impairs adipocyte differentiation and function, 2015, pp.64, 1180~1192
217. Nishimura, S., "ENPP2 contributes to adipose tissue expansion and insulin resistance in diet-induced obesity", Diabetes, 63, pp.4154~4164 (2014)
218. Federico, L., "Autotaxin and its product lysophosphatidic acid suppress brown adipose differentiation and promote diet-induced obesity in mice", Mol. Endocrinol, 26, pp.786~797 (2012)
219. Kim Goon-Tae, "Upregulation of the serine palmitoyltransferase subunit SPTLC2 by endoplasmic reticulum stress inhibits the hepatic insulin response", Experimental and Molecular Medicine, 54, pp.1~12 (2022), 생화학분자생물학회[DOI]
220. Li, Y., "Sphingomyelin synthase 2 activity and liver steatosis : an effect of ceramide-mediated peroxisome proliferator-activated receptor γ2 suppression", Arterioscler. Thromb. Vasc. Biol, 33, pp.1513~1520 (2013)
221. Fan, S., "Hepatocyte-specific deletion of LASS2 protects against diet-induced hepatic steatosis and insulin resistance", Free Radic. Biol. Med, 120, pp.330~341 (2018)
222. Osawa, Y., "Acid sphingomyelinase regulates glucose and lipid metabolism in hepatocytes through AKT activation and AMP-activated protein kinase suppression", FASEB J, 25, pp.1133~1144 (2011)
223. Lan, T., "Sphingosine kinase 1 promotes liver fibrosis by preventing miR-19b-3p-mediated inhibition of CCR2", Hepatology, 68, pp.1070~1086 (2018)
224. Qiu, H., "Hepatocyte-secreted autotaxin exacerbates nonalcoholic fatty liver disease through autocrine inhibition of the PPARα", FGF21 axis, 2022, pp.14, 1003~1023
225. Fucho, R., "ASMase regulates autophagy and lysosomal membrane permeabilization and its inhibition prevents early stage non-alcoholic steatohepatitis", J. Hepatol, 61, pp.1126~1134 (2014)

관련 논문AI추천